Sec. 809. Public docket on proposed changes to third-party vendors
276 words·~1 min read·
/bill/117/hr/7667/rh/section-809A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
Not later than 90 days after the date of enactment of this Act, the Secretary of Health and Human Services shall open a single public docket to solicit comments on factors that generally should be considered by the Secretary when reviewing requests from sponsors of drugs subject to risk evaluation and mitigation strategies to change third-party vendors engaged by sponsors to aid in implementation and management of the strategies. Such factors include the potential effects of changes in third-party vendors on— patient access; and prescribing and administration of the drugs by health care providers.
The Secretary of Health and Human Services may close such public docket not earlier than 90 days after such docket is opened. Nothing in this section shall delay agency action on any modification to a risk evaluation and mitigation strategy. Not later than December 31, 2026, the Comptroller General of the United States shall submit to the Committee on Energy and Commerce of the House of Representatives and the Committee on Health, Education, Labor, and Pensions of the Senate a report on— the number of changes in third-party vendors (engaged by sponsors to aid implementation and management of risk evaluation and mitigation strategies) for an approved risk evaluation and mitigation strategy the Secretary of Health and Human Services has approved under section 505–1(h) of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 355–1(h) ); any issues affecting patient access to the drug that is subject to the strategy or considerations with respect to the administration or prescribing of such drug by health care providers that arose as a result of such modifications; and how such issues were resolved, as applicable.